Literature DB >> 16291522

Blackfoot disease and arsenic: a never-ending story.

Chin-Hsiao Tseng1.   

Abstract

Blackfoot disease (BFD) is an endemic peripheral vascular disease confined to the southwestern coast of Taiwan. This article reviews the epidemiology, clinical manifestations and diagnosis, pathology, etiology and pathogenesis of this disease. Sporadic cases of BFD occurred as early as in the early 20th century, and peak incidence was noted between 1956 and 1960, with prevalence rates ranging from 6.51 to 18.85 per 1,000 population in different villages. Typical clinical symptoms and signs of progressive arterial occlusion mainly found in the lower extremities, but in rare cases, the upper extremities might also be involved. Ulceration, gangrene and spontaneous or surgical amputation were typical fate. An extensive pathological study concluded that 30% of the BFD patients had histologic lesions compatible with thromboangiitis obliterans and 70% showed changes of arteriosclerosis obliterans. Epidemiologic studies carried out since mid-20th century revealed that BFD was associated with the consumption of inorganic arsenic from the artesian wells. Recent studies confirmed the existence of preclinical peripheral vascular disease, subclinical arterial insufficiency and defects in cutaneous microcirculation in the residents of the endemic villages. A more recent study suggested that the methylation capacity of arsenic can interact with arsenic exposure in the development of peripheral vascular disease among residents of BFD-endemic areas. The incidence of BFD decreased dramatically after the implementation of tap water in these villages over the past 2-3 decades. The atherogenicity of arsenic could be associated with its effects of hypercoagulability, endothelial injury, smooth muscle cell proliferation, somatic mutation, oxidative stress, and apoptosis. However, its interaction with some trace elements and its association with hypertension and diabetes mellitus could also explain part of its higher risk of developing atherosclerosis. Although humic substances have also been suggested as a possible cause of BFD, epidemiologic studies are required to confirm its etiologic role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291522     DOI: 10.1081/GNC-200051860

Source DB:  PubMed          Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev        ISSN: 1059-0501            Impact factor:   3.781


  25 in total

1.  Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China.

Authors:  Xushen Chen; Xiaojuan Guo; Ping He; Jing Nie; Xiaoyan Yan; Jinqiu Zhu; Luoping Zhang; Guangyun Mao; Hongmei Wu; Zhiyue Liu; Diana Aga; Peilin Xu; Martyn Smith; Xuefeng Ren
Journal:  Toxicol Sci       Date:  2016-09-16       Impact factor: 4.849

2.  Ethnic characterization of a population of children exposed to high doses of arsenic via drinking water and a possible correlation with metabolic processes.

Authors:  Cecilia Bobillo; Julio A Navoni; Valentina Olmos; Luciano J Merini; Edda Villaamil Lepori; Daniel Corach
Journal:  Int J Mol Epidemiol Genet       Date:  2014-02-17

3.  A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh.

Authors:  Maria Argos; Tara Kalra; Brandon L Pierce; Yu Chen; Faruque Parvez; Tariqul Islam; Alauddin Ahmed; Rabiul Hasan; Khaled Hasan; Golam Sarwar; Diane Levy; Vesna Slavkovich; Joseph H Graziano; Paul J Rathouz; Habibul Ahsan
Journal:  Am J Epidemiol       Date:  2011-05-16       Impact factor: 4.897

4.  Complexation of arsenite with humic acid in the presence of ferric iron.

Authors:  Guangliang Liu; Aymara Fernandez; Yong Cai
Journal:  Environ Sci Technol       Date:  2011-02-15       Impact factor: 9.028

5.  Complexation of arsenite with dissolved organic matter: conditional distribution coefficients and apparent stability constants.

Authors:  Guangliang Liu; Yong Cai
Journal:  Chemosphere       Date:  2010-11       Impact factor: 7.086

Review 6.  A Clinical Perspective on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease.

Authors:  Gurleen Kaur; Karan P Desai; Isabella Y Chang; Jonathan D Newman; Roy O Mathew; Sripal Bangalore; Ferdinand J Venditti; Mandeep S Sidhu
Journal:  Cardiovasc Drugs Ther       Date:  2022-01-14       Impact factor: 3.727

7.  Induction of metallothionein I by arsenic via metal-activated transcription factor 1: critical role of C-terminal cysteine residues in arsenic sensing.

Authors:  Xiaoqing He; Qiang Ma
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

Review 8.  Arsenic exposure and cardiovascular disease: an updated systematic review.

Authors:  Katherine Moon; Eliseo Guallar; Ana Navas-Acien
Journal:  Curr Atheroscler Rep       Date:  2012-12       Impact factor: 5.113

9.  Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.

Authors:  Katherine A Moon; Eliseo Guallar; Jason G Umans; Richard B Devereux; Lyle G Best; Kevin A Francesconi; Walter Goessler; Jonathan Pollak; Ellen K Silbergeld; Barbara V Howard; Ana Navas-Acien
Journal:  Ann Intern Med       Date:  2013-11-19       Impact factor: 25.391

Review 10.  Trace elements in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Marcello Tonelli; Natasha Wiebe; Brenda Hemmelgarn; Scott Klarenbach; Catherine Field; Braden Manns; Ravi Thadhani; John Gill
Journal:  BMC Med       Date:  2009-05-19       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.